Publications scientifiques

Fuentes S, Hrzic R, Haneef R, Kab S, Cosson E, Fosse-Edorh S. Identifying type 1 / type 2 diabetes in medico-administrative database to improve health surveillance, medical research and prevention in diabetes: Algorithm development and application. Diabet Epidemiol Manag. 2023 Apr;10:100137. DOI: https://dx.doi.org/10.1016/j.deman.2023.100137. HAL: https://hal.science/hal-04165493v1

Le Noan-Lainé M, Artaud F, Ndoadoumgue AL, Ozguler A, Cœuret-Pellicer M, Ringa V, Elbaz A, Canonico M. Characteristics of reproductive history, use of exogenous hormones and walking speed among women: Data from the CONSTANCES French Cohort Study. Maturitas. 2023 Apr;170:42-50. DOI: https://dx.doi.org/10.1016/j.maturitas.2023.01.008. HAL: https://hal.science/hal-04021837v1

Fadel M, Sembajwe G, Li J, Leclerc A, Pico F, Schnitzler A, Roquelaure Y, Descatha A. Association between prolonged exposure to long working hours and stroke subtypes in the CONSTANCES cohort. Occup Environ Med. 2023 Apr;80(4):196-201. DOI: https://dx.doi.org/10.1136/oemed-2022-108656. HAL: https://hal.science/hal-04041101v1

Deschasaux-Tanguy M, Szabo de Edelenyi F, Druesne-Pecollo N, Esseddik Y, Allègre J, Srour B, Galan P, Hercberg S, Severi G, Zins M, Wiernik E; SAPRIS-SERO study group; de Lamballerie X, Carrat F, Touvier M. ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study. Sci Rep. 2023 Mar;13(1):4775. DOI: https://dx.doi.org/10.1038/s41598-023-30714-9. HAL: https://hal.science/hal-04059423

Rolland AL, Porro B, Kab S, Ribet C, Roquelaure Y, Bertin M. Impact of breast cancer care pathways and related symptoms on the return-to-work process: results from a population-based French cohort study (CONSTANCES). Breast Cancer Res. 2023 Mar;25(1):30. DOI: https://dx.doi.org/10.1186/s13058-023-01623-6. HAL: https://hal.science/hal-04044167v1

Amadou C, Heude B, de Lauzon-Guillain B, Lioret S, Descarpentrie A, Ribet C, Zins M, Charles MA. Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population. Diabetes Metab. 2023 Mar;49(2):101414. DOI: https://dx.doi.org/10.1016/j.diabet.2022.101414. HAL: https://hal.science/hal-04021772v1

Amadou C, Nabi O, Serfaty L, Lacombe K, Boursier J, Mathurin P, Ribet C, De Ledinghen V, Zins M, Charles M. Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort (Author’s reply). Hepatology. 2023 Feb;77(2):E18. DOI: https://dx.doi.org/10.1002/hep.32649. HAL: https://hal.sorbonne-universite.fr/hal-03777509

Haddad RE, Matta J, Lemogne C, Melchior M, Zins M, Airagnes G. The association between substance use and subsequent employment among students: prospective findings from the CONSTANCES cohort. Soc Psychiatry Psychiatr Epidemiol. 2023 Feb;58(2):249-266. DOI: https://dx.doi.org/10.1007/s00127-022-02357-0. HAL: https://hal.science/hal-04021613v1

Savouré M, Bousquet J, Leynaert B, Renuy A, Siroux V, Goldberg M, Zins M, Jacquemin B, Nadif R. Rhinitis phenotypes and multimorbidities in the general population: the CONSTANCES cohort. Eur Respir J. 2023 Feb;61(2):2200943. DOI: https://dx.doi.org/10.1183/13993003.00943-2022. HAL: https://hal.science/inserm-04052291v1

Foerster M, Dufour L, Bäumler W, Schreiver I, Goldberg M, Zins M, Ezzedine K, Schüz J. Development and Validation of the Epidemiological Tattoo Assessment Tool to Assess Ink Exposure and Related Factors in Tattooed Populations for Medical Research: Cross-sectional Validation Study. JMIR Form Res. 2023 Jan;7:e42158. DOI: https://dx.doi.org/10.2196/42158. HAL: https://hal.science/hal-04474859v1

Roche N, Nadif R, Fabry-Vendrand C, Pillot L, Thabut G, Teissier C, Bouée S, Goldberg M, Zins M. Asthma burden according to treatment steps in the French population-based cohort CONSTANCES. Respir Med. 2023 Jan;206:107057. DOI: https://dx.doi.org/10.1016/j.rmed.2022.107057. HAL: https://hal.science/hal-03949592v1

Sokal A, Bastard P, Chappert P, Barba-Spaeth G, Fourati S, Vanderberghe A, Lagouge-Roussey P, Meyts I, Gervais A, Bouvier-Alias M, Azzaoui I, Fernández I, De La Selle A, Zhang Q, Bizien L, Pellier I, Linglart A, Rothenbuhler A, Marcoux E, Anxionnat R, Cheikh N, Léger J, Amador-Borrero B, Fouyssac F, Menut V, Goffard JC, Storey C, Demily C, Mallebranche C, Troya J, et al. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination. J Exp Med. 2023 Jan;220(1):e20220258. DOI: https://dx.doi.org/10.1084/jem.20220258. HAL: https://hal.science/pasteur-03847416v1